logo
Sign in

CMOPF Stock Price, Chart, Stats & News

Cosmo Pharmaceuticals N.V.
Save

Cosmo Pharmaceuticals N.V. (CMOPF) is a dividend-paying stock with a current dividend yield of 6.56% as of Aug 13, 2026. It pays $4.93 per share over the trailing twelve months and distributes bi-annually.

1.29B
Market cap
Current P/E
2500.00x
Forward P/E
6.56%
Dividend yield

CMOPF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Medical - Pharmaceuticals
Industry

Cosmo Pharmaceuticals N. V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Rifamycin, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers' diarrhoea; and Clascoterone, which is in phase-3 clinical trial for the treatment of male pattern hair loss.

Related lists

Similar securities

Based on sector and market capitalization

Report issue